Fulcrum Therapeutics Strengthens Leadership Team with the Appointments of Isabel Kalofonos as Chief Commercial Officer and Heather Faulds as Chief Regulatory Affairs & Quality Assurance Officer
CAMBRIDGE, Mass., Aug. 19, 2024 ( GLOBE NEWSWIRE ) -- Fulcrum Therapeutics, Inc.® ( Fulcrum ) ( Nasdaq: FULC ) , a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced the ...
| Ticker |
Sentiment |
Impact |
|
ALKS
|
Neutral
|
2 %
|
|
SRRK
|
Neutral
|
5 %
|
|
BIIB
|
Neutral
|
5 %
|
|
FULC
|
Neutral
|
9 %
|
